SCHEMBL4261005

SCHEMBL4261005

CNCCCOc1cc(F)c(-c2c(Cl)nc(-n3cccn3)c(=O)n2-c2cccc(F)c2)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CACNA2D1 P54289 1/20 0.32
MAT2A P31153 3/20 0.32
TGFBR1 P36897 1/20 0.32
ALDH1A1 P00352 2/20 0.31
ALDH1A2 O94788 1/20 0.31
ALDH1A3 P47895 1/20 0.31
WEE1 P30291 1/20 0.31
KAT6A Q92794 1/20 0.31
SLC6A2 P23975 1/20 0.31
RORC P51449 1/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
TP53 P04637 1/20 0.30
HTR1B P28222 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4497287 0.89 HTR2A (0.36) MEN1KMT2ACACNA2D1MAT2ATGFBR1
SCHEMBL4877684 0.84 MAT2A (0.39) MEN1KMT2AMAT2ATGFBR1KAT6A
SCHEMBL3988447 0.80 KDM4E (0.32) ALDH1A1WEE1KDM4E
SCHEMBL4489726 0.79 KDM4E (0.30) ALDH1A1KDM4E
SCHEMBL4484643 0.76 WEE1 (0.30) WEE1
SCHEMBL13788904 0.76 MAT2A (0.42) MEN1KMT2AMAT2AALDH1A1ALDH1A2
SCHEMBL4882519 0.75 MAT2A (0.45) MAT2AALDH1A1KAT6AKDM4EHPGD
SCHEMBL4882430 0.71 MAT2A (0.46) MAT2AALDH1A1KAT6AKDM4EHPGD
SCHEMBL4745295 0.70 KDM4E (0.32) KDM4E
SCHEMBL4489416 0.69 KDM4E (0.32) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-07-23 US claimed
EP-2034993-A2 PYRAZINONES AS CELLULAR PROLIFERATION INHIBITORS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-03-18 EP claimed
WO-2007149448-A2 PYRAZINONES AS CELLULAR PROLIFERATION INHIBITORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-12-27 WO claimed
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors MKI67, NR0B1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HRH3 992/4885MEN1 2022/4885KMT2A 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.